|
24 Mar 2025 |
BASF
|
Consensus Share Price Target
|
4516.55 |
5342.00 |
- |
18.28 |
buy
|
|
|
|
|
11 Nov 2019
|
BASF
|
Emkay
|
4516.55
|
1115.00
|
990.35
(356.06%)
|
Target met |
Hold
|
|
|
Q2FY20 revenues were above our estimates, mainly due to a change in revenue recognition model. Revenue was up 24% yoy to Rs20.7bn (our est. of Rs17.5bn). EBITDA stood at Rs761mn vs. our est. of Rs669mn. Strong growth in Agriculture solutions (+17%), Industrial Solution (+10%) and Nutrition & Care (+82%) segments was partially offset by its Materials segment (-7%). The company has switched to a merchandise business model from an agency business model, due to which, the Chemicals segment revenues jumped eightfold yoy to Rs3.1bn. 166bps/189bps yoy while the Nutrition & care segment and Surface Technologies segments...
|